ECTOPIC ACTH SECRETION

Clinical trials for ECTOPIC ACTH SECRETION explained in plain language.

Never miss a new study

Get alerted when new ECTOPIC ACTH SECRETION trials appear

Sign up with your email to follow new studies for ECTOPIC ACTH SECRETION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug tested to tame dangerous hormone flood

Disease control Completed

This study tested an investigational drug called SPI-62 to see if it could safely reduce the harmful excess cortisol caused by ACTH-dependent Cushing's syndrome. For 24 weeks, 26 adult participants received either the drug or a placebo, with an option to continue on the drug long…

Matched conditions: ECTOPIC ACTH SECRETION

Phase: PHASE2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control

Last updated Apr 02, 2026 05:11 UTC

ECTOPIC ACTH SECRETION

Get alerted when new ECTOPIC ACTH SECRETION trials appear

New drug tested to tame dangerous hormone flood